Targeted angiogenesis

Details for Australian Patent Application No. 2005204270 (hide)

Owner Edwards Lifesciences Corporation Baxter Aktiengesellschaft

Inventors Mitterer, Artur; Dorner, Friedrich; Falkner, Falko-Guenter; Scheiflinger, Friedrich; Levine, Arnold J

Agent Peter Maxwell & Associates

Pub. Number AU-A-2005204270

Parent 781

Filing date 26 August 2005

Wipo publication date 22 September 2005

International Classifications

C12N 015/19 Mutation or genetic engineering - Interferons

A61K 038/19 Medicinal preparations containing peptides - Cytokines

C12N 015/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

C07K 014/52 Peptides having more than 20 amino acids

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

8 September 2005 Complete Application Filed

22 September 2005 Application Open to Public Inspection

  Published as AU-A-2005204270

8 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005204271-Adventure sequence activities

2005204269-Improvements in and relating to vine growth